(Q35794558)

10 August 2017

1 reference

title

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease (English)

1 reference

10 August 2017

0 references

Lorenzo M Refolo

1

1 reference

PubMed ID

15181243

10 August 2017

Howard M Fillit

series ordinal

2

1 reference

10 August 2017

1 January 2004

1 reference

Journal of Molecular Neuroscience

10 August 2017

1 reference

10 August 2017

23

1 reference

10 August 2017

3

1 reference

10 August 2017

151-155

1 reference

https://scigraph.springernature.com/pub.10.1385/jmn:23:3:151

10 August 2017

0 references

cites work

Strategies for drug discovery for cognitive aging and Alzheimer's disease.

1 reference

12 December 2020

APO E gene and gene-environment effects on plasma lipoprotein-lipid levels

1 reference

12 December 2020

Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo

1 reference

12 December 2020

Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.

1 reference

12 December 2020

Lipoprotein and receptor interactions in vivo.

1 reference

12 December 2020

APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response

1 reference

12 December 2020

Alzheimer disease as a vascular disorder: nosological evidence

1 reference

12 December 2020

Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges

1 reference

12 December 2020

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

1 reference

12 December 2020

SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides

1 reference

12 December 2020

Apolipoprotein E: structure-function relationships

1 reference

12 December 2020

Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy

1 reference

12 December 2020

Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice

1 reference

12 December 2020

Cholesterol metabolism in the brain

1 reference

12 December 2020

Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons

1 reference

12 December 2020

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

12 December 2020

Apolipoprotein E: far more than a lipid transport protein

1 reference

12 December 2020

Apolipoprotein E in neurology

1 reference

12 December 2020

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.

1 reference

12 December 2020

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

12 December 2020

Inflammatory processes in Alzheimer's disease

1 reference

12 December 2020

Link between heart disease, cholesterol, and Alzheimer's disease: a review

1 reference

12 December 2020

Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E

1 reference

12 December 2020

Amyloid, the presenilins and Alzheimer's disease

1 reference

12 December 2020

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

12 December 2020

Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses

1 reference

12 December 2020

Non-familial Alzheimer's disease is mainly due to genetic factors.

1 reference

12 December 2020

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

12 December 2020

Isoform-specific binding of apolipoprotein E to beta-amyloid

1 reference

12 December 2020

Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function

1 reference

12 December 2020

Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains

1 reference

12 December 2020

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

12 December 2020

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:23:3:151

1 reference

PubMed ID

15181243

Dimensions Publication ID

10 August 2017

0 references

1 reference

PubMed ID

15181243